Acoustofluidic Interfaces for the Mechanobiological Secretome of MSCs

Ye He(Duke University), Shujie Yang(Duke University), Pengzhan Liu(Duke University), Ke Li(Duke University), Ke Jin(Duke University), Ryan Becker(Duke University), Jinxin Zhang(Duke University), Chuanchuan Lin(Xinqiao Hospital), Jianping Xia(Duke University), Zhehan Ma(Duke University), Zhiteng Ma(Duke University), Ruoyu Zhong(Duke University), Luke P. Lee(Brigham and Women's Hospital), Tony Jun Huang(Duke University)
Nature Communications
November 22, 2023
Cited by 32Open Access
Full Text

Abstract

While mesenchymal stem cells (MSCs) have gained enormous attention due to their unique properties of self-renewal, colony formation, and differentiation potential, the MSC secretome has become attractive due to its roles in immunomodulation, anti-inflammatory activity, angiogenesis, and anti-apoptosis. However, the precise stimulation and efficient production of the MSC secretome for therapeutic applications are challenging problems to solve. Here, we report on Acoustofluidic Interfaces for the Mechanobiological Secretome of MSCs: AIMS. We create an acoustofluidic mechanobiological environment to form reproducible three-dimensional MSC aggregates, which produce the MSC secretome with high efficiency. We confirm the increased MSC secretome is due to improved cell-cell interactions using AIMS: the key mediator N-cadherin was up-regulated while functional blocking of N-cadherin resulted in no enhancement of the secretome. After being primed by IFN-γ, the secretome profile of the MSC aggregates contains more anti-inflammatory cytokines and can be used to inhibit the pro-inflammatory response of M1 phenotype macrophages, suppress T cell activation, and support B cell functions. As such, the MSC secretome can be modified for personalized secretome-based therapies. AIMS acts as a powerful tool for improving the MSC secretome and precisely tuning the secretory profile to develop new treatments in translational medicine.


Related Papers